INDIANA — K.C. Pharmaceuticals has issued a massive voluntary recall involving more than 3.1 million bottles of over-the-counter eye drops. The move comes after the Food and Drug Administration (FDA) raised alarms regarding a “lack of assurance of sterility” at the manufacturing level.
The recall, which officially began in early March, affects a wide range of house-brand products sold at major national retailers, including CVS, Walgreens, and Rite Aid.
The FDA has designated this as a Class II recall. This classification is used when a product may cause temporary or medically reversible adverse health consequences, but the probability of serious harm is remote.
While the recall is significant in scale—totaling 3,111,072 bottles—there have been no reported injuries or infections associated with the products to date. According to FDA guidelines, consumers can typically continue using medications during a Class II recall unless otherwise instructed by the manufacturer, though caution is advised with ocular products due to the sensitivity of the eyes.
The recall impacts several formulations of lubricating and redness-relief drops. Consumers should check their medicine cabinets for the following 0.5 fl oz (15 mL) bottles:
- Sterile Eye Drops AC (Tetrahydrozoline HCl/Zinc Sulfate)
- EYE DROPS Advanced Relief (Dextran 70/Polyethylene Glycol/Tetrahydrozoline)
- Dry Eye Relief Eye Drops (Glycerin/Hypromellose/Polyethylene Glycol)
- Ultra Lubricating Eye Drops (Polyethylene/Propylene Glycol)
- Sterile Eye Drops Original Formula (Tetrahydrozoline HCl)
- Sterile Eye Drops Redness Lubricant (Glycerin/Naphazoline HCl)
- Sterile Eye Drops Soothing Tears (Polyethylene Glycol/Propylene Glycol)
- Artificial Tears Sterile Lubricant Eye Drops (Polyvinyl Alcohol/Povidone)
The FDA’s concern over “assurance of sterility” is particularly critical for eye products. Because the eyes have fewer natural defenses than the skin, contaminated drops can lead to serious issues if bacteria or fungi are introduced directly to the eyeball.
While this specific recall is preventative, previous unrelated eye drop recalls in recent years have been linked to Pseudomonas aeruginosa, a drug-resistant bacterium that can cause permanent vision loss or systemic infections. This history has led the FDA to increase its oversight and inspections of ophthalmic manufacturing facilities.
What Consumers Should Do
If you possess any of the recalled products, experts recommend the following steps:
- Verify the Brand: Check if your store-brand drops (CVS, Walgreens, etc.) were manufactured by K.C. Pharmaceuticals.
- Monitor for Symptoms: Watch for signs of eye infection, such as unusual redness, discharge, pain, or blurred vision.
- Consult a Professional: If you have used these drops and experience discomfort, contact an optometrist or ophthalmologist immediately.
K.C. Pharmaceuticals has not yet provided a detailed explanation regarding the specific manufacturing lapse that triggered the recall. Retailers have been instructed to remove the affected lots from their shelves immediately.
